{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:11:22Z","timestamp":1790172682992,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Optimal treatment of brain metastases is often hindered by limitations in diagnostic capabilities. To meet this challenge, here we profile DNA methylomes of the three most frequent types of brain metastases: melanoma, breast, and lung cancers (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200996). Using supervised machine learning and integration of DNA methylomes from normal, primary, and metastatic tumor specimens (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20091860), we unravel epigenetic signatures specific to each type of metastatic brain tumor and constructed a three-step DNA methylation-based classifier (BrainMETH) that categorizes brain metastases according to the tissue of origin and therapeutically relevant subtypes. BrainMETH predictions are supported by routine histopathologic evaluation. We further characterize and validate the most predictive genomic regions in a large cohort of brain tumors (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009165) using quantitative-methylation-specific PCR. Our study highlights the importance of brain tumor-defining epigenetic alterations, which can be utilized to further develop DNA methylation profiling as a critical tool in the histomolecular stratification of patients with brain metastases.\n                  <\/jats:p>","DOI":"10.1038\/s41467-018-06715-y","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T05:41:00Z","timestamp":1540964460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Epigenetic profiling for the molecular classification of metastatic brain tumors"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2585-358X","authenticated-orcid":false,"given":"Javier I. J.","family":"Orozco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo A.","family":"Knijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla O.","family":"Manughian-Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6615-7428","authenticated-orcid":false,"given":"Garni","family":"Barkhoudarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Jalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Wilmott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvinder","family":"Hothi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Takasumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Buckland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8894-3545","authenticated-orcid":false,"given":"Georgina V.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Cobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Shmulevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1915-3683","authenticated-orcid":false,"given":"Dave S. B.","family":"Hoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3258-8852","authenticated-orcid":false,"given":"Diego M.","family":"Marzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,6]]},"reference":[{"key":"6715_CR1","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/cncr.10541","volume":"94","author":"LJ Schouten","year":"2002","unstructured":"Schouten, L. J., Rutten, J., Huveneers, H. A. & Twijnstra, A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94, 2698\u20132705 (2002).","journal-title":"Cancer"},{"key":"6715_CR2","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","volume":"22","author":"JS Barnholtz-Sloan","year":"2004","unstructured":"Barnholtz-Sloan, J. S. et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J. Clin. Oncol. 22, 2865\u20132872 (2004).","journal-title":"J. Clin. Oncol."},{"key":"6715_CR3","doi-asserted-by":"publisher","first-page":"e000024","DOI":"10.1136\/esmoopen-2015-000024","volume":"1","author":"AS Berghoff","year":"2016","unstructured":"Berghoff, A. S. et al. Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers. ESMO Open 1, e000024 (2016).","journal-title":"ESMO Open"},{"issue":"11","key":"6715_CR4","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","volume":"19","author":"Daniel N Cagney","year":"2017","unstructured":"Cagney, D. N. et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: A population-based study. Neuro Oncol. 19, 1511-1521 (2017).","journal-title":"Neuro-Oncology"},{"key":"6715_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11060-004-8093-6","volume":"75","author":"IT Gavrilovic","year":"2005","unstructured":"Gavrilovic, I. T. & Posner, J. B. Brain metastases: epidemiology and pathophysiology. J. Neurooncol. 75, 5\u201314 (2005).","journal-title":"J. Neurooncol."},{"key":"6715_CR6","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1200\/JCO.2015.60.9503","volume":"33","author":"X Lin","year":"2015","unstructured":"Lin, X. & DeAngelis, L. M. Treatment of brain metastases. J. Clin. Oncol. 33, 3475\u20133484 (2015).","journal-title":"J. Clin. Oncol."},{"key":"6715_CR7","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1200\/JCO.2013.54.0955","volume":"32","author":"N Ramakrishna","year":"2014","unstructured":"Ramakrishna, N. et al. Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline. J. Clin. Oncol. 32, 2100\u20132108 (2014).","journal-title":"J. Clin. Oncol."},{"key":"6715_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdx374.047","volume":"28","author":"R Costa","year":"2017","unstructured":"Costa, R. et al. Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives. Ann. Oncol. 28, 44\u201356 (2017).","journal-title":"Ann. Oncol."},{"key":"6715_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10014-016-0275-3","volume":"34","author":"L Bekaert","year":"2017","unstructured":"Bekaert, L., Emery, E., Levallet, G. & Lechapt-Zalcman, E. Histopathologic diagnosis of brain metastases: current trends in management and future considerations. Brain Tumor Pathol. 34, 8\u201319 (2017).","journal-title":"Brain. Tumor Pathol."},{"key":"6715_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/01.jnen.0000235124.82805.2b","volume":"65","author":"MW Becher","year":"2006","unstructured":"Becher, M. W., Abel, T. W., Thompson, R. C., Weaver, K. D. & Davis, L. E. Immunohistochemical analysis of metastatic neoplasms of the central nervous system. J. Neuropathol. Exp. Neurol. 65, 935\u2013944 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"6715_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cell.2016.12.015","volume":"168","author":"DM Hyman","year":"2017","unstructured":"Hyman, D. M., Taylor, B. S. & Baselga, J. Implementing genome-driven oncology. Cell 168, 584\u2013599 (2017).","journal-title":"Cell"},{"key":"6715_CR12","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(16)30297-2","volume":"17","author":"S Moran","year":"2016","unstructured":"Moran, S. et al. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Lancet Oncol. 17, 1386\u20131395 (2016).","journal-title":"Lancet Oncol."},{"key":"6715_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469\u2013474 (2018).","journal-title":"Nature"},{"key":"6715_CR14","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1093\/neuonc\/nou107","volume":"16","author":"DM Marzese","year":"2014","unstructured":"Marzese, D. M. et al. DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations. Neuro Oncol. 16, 1499\u20131509 (2014).","journal-title":"Neuro. Oncol."},{"key":"6715_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/hmg\/ddt420","volume":"23","author":"DM Marzese","year":"2014","unstructured":"Marzese, D. M. et al. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum. Mol. Genet. 23, 226\u2013238 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"6715_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.gdata.2014.06.007","volume":"2","author":"DM Marzese","year":"2014","unstructured":"Marzese, D. M., Huynh, J. L., Kawas, N. P. & Hoon, D. S. Multi-platform genome-wide analysis of melanoma progression to brain metastasis. Genom. Data 2, 150\u2013152 (2014).","journal-title":"Genom. Data"},{"key":"6715_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/pcmr.12307","volume":"28","author":"DM Marzese","year":"2015","unstructured":"Marzese, D. M. et al. Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome. Pigment Cell Melanoma Res. 28, 82\u201393 (2015).","journal-title":"Pigment. Cell. Melanoma Res."},{"key":"6715_CR18","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","DOI":"10.1038\/nature11412"},{"key":"6715_CR19","unstructured":"The Cancer Genome Atlas Network. Genomic classification of cutaneous melanoma. Cell 161, 1681-1696 (2015)."},{"key":"6715_CR20","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou, W., Laird, P. W. & Shen, H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 45, e22\u2013e22 (2017).","journal-title":"Nucleic Acids Res."},{"key":"6715_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.4161\/epi.6.6.16196","volume":"6","author":"J Sandoval","year":"2011","unstructured":"Sandoval, J. et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6, 692\u2013702 (2011).","journal-title":"Epigenetics"},{"key":"6715_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/epi.23470","volume":"8","author":"YA Chen","year":"2013","unstructured":"Chen, Y. A. et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8, 203\u2013209 (2013).","journal-title":"Epigenetics"},{"key":"6715_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2217\/epi.15.114","volume":"8","author":"S Moran","year":"2016","unstructured":"Moran, S., Arribas, C. & Esteller, M. Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics 8, 389\u2013399 (2016).","journal-title":"Epigenomics"},{"key":"6715_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00234-015-1524-6","volume":"57","author":"AH Bauer","year":"2015","unstructured":"Bauer, A. H., Erly, W., Moser, F. G., Maya, M. & Nael, K. Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion. Neuroradiology 57, 697\u2013703 (2015).","journal-title":"Neuroradiology"},{"key":"6715_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","volume":"164","author":"M Ceccarelli","year":"2016","unstructured":"Ceccarelli, M. et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164, 550\u2013563 (2016).","journal-title":"Cell"},{"key":"6715_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9971","volume":"6","author":"D Aran","year":"2015","unstructured":"Aran, D., Sirota, M. & Butte, A. J. Systematic pan-cancer analysis of tumour purity. Nat. Commun. 6, 8971 (2015).","journal-title":"Nat. Commun."},{"key":"6715_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.1630","volume":"28","author":"CY McLean","year":"2010","unstructured":"McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495\u2013501 (2010).","journal-title":"Nat. Biotechnol."},{"key":"6715_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1148\/radiol.2016161382","volume":"281","author":"P Kickingereder","year":"2016","unstructured":"Kickingereder, P. et al. Radiogenomics of glioblastoma: machine learning-based classification of molecular characteristics by using multiparametric and multiregional MR imaging features. Radiology 281, 907\u2013918 (2016).","journal-title":"Radiology"},{"key":"6715_CR29","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1158\/1078-0432.CCR-13-1157","volume":"19","author":"MJ van den Bent","year":"2013","unstructured":"van den Bent, M. J. et al. MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic oligodendrogliomas and oligoastrocytomas. a report from EORTC study 26951. Clin. Cancer Res. 19, 5513\u20135522 (2013).","journal-title":"Clin. Cancer Res."},{"key":"6715_CR30","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","volume":"156","author":"M Valiente","year":"2014","unstructured":"Valiente, M. et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 156, 1002\u20131016 (2014).","journal-title":"Cell"},{"key":"6715_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1158\/1541-7786.MCR-11-0534","volume":"10","author":"LD Ridgway","year":"2012","unstructured":"Ridgway, L. D., Wetzel, M. D., Ngo, J. A., Erdreich-Epstein, A. & Marchetti, D. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells. Mol. Cancer Res. 10, 689\u2013702 (2012).","journal-title":"Mol. Cancer Res."},{"key":"6715_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"6715_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/modpathol.2010.200","volume":"24","author":"S Badve","year":"2011","unstructured":"Badve, S. et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod. Pathol. 24, 157\u2013167 (2011).","journal-title":"Mod. Pathol."},{"key":"6715_CR34","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nm0809-842","volume":"15","author":"A Prat","year":"2009","unstructured":"Prat, A. & Perou, C. M. Mammary development meets cancer genomics. Nat. Med. 15, 842\u2013844 (2009).","journal-title":"Nat. Med."},{"key":"6715_CR35","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049","volume":"158","author":"KA Hoadley","year":"2014","unstructured":"Hoadley, K. A. et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158, 929\u2013944 (2014).","journal-title":"Cell"},{"key":"6715_CR36","doi-asserted-by":"publisher","first-page":"S245","DOI":"10.4103\/2152-7806.111302","volume":"4","author":"M Pekmezci","year":"2013","unstructured":"Pekmezci, M. & Perry, A. Neuropathology of brain metastases. Surg. Neurol. Int. 4, S245\u2013S255 (2013).","journal-title":"Surg. Neurol. Int."},{"key":"6715_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10014-015-0235-3","volume":"33","author":"H Takei","year":"2016","unstructured":"Takei, H., Rouah, E. & Ishida, Y. Brain metastasis: clinical characteristics, pathological findings and molecular subtyping for therapeutic implications. Brain Tumor Pathol. 33, 1\u201312 (2016).","journal-title":"Brain. Tumor Pathol."},{"key":"6715_CR38","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00401-017-1743-5","volume":"134","author":"P Euskirchen","year":"2017","unstructured":"Euskirchen, P. et al. Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing. Acta Neuropathol. 134, 691\u2013703 (2017).","journal-title":"Acta Neuropathol."},{"key":"6715_CR39","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/neuonc\/now197","volume":"19","author":"MC Chamberlain","year":"2017","unstructured":"Chamberlain, M. C., Baik, C. S., Gadi, V. K., Bhatia, S. & Chow, L. Q. Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma. Neuro Oncol. 19, i1\u2013i24 (2017).","journal-title":"Neuro. Oncol."},{"key":"6715_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/annonc\/mdx447","volume":"28","author":"F Cardoso","year":"2017","unstructured":"Cardoso, F. et al. 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). Ann. Oncol. 28, 16\u201333 (2017).","journal-title":"Ann. Oncol."},{"key":"6715_CR41","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10549-017-4526-8","volume":"167","author":"O Kaidar-Person","year":"2018","unstructured":"Kaidar-Person, O. et al. Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study. Breast Cancer Res. Treat. 167, 479\u2013483 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"6715_CR42","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/bjc.2016.34","volume":"114","author":"AH Thomson","year":"2016","unstructured":"Thomson, A. H. et al. Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes. Br. J. Cancer 114, 793\u2013800 (2016).","journal-title":"Br. J. Cancer"},{"key":"6715_CR43","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","volume":"5","author":"PK Brastianos","year":"2015","unstructured":"Brastianos, P. K. et al. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov. 5, 1164\u20131177 (2015).","journal-title":"Cancer Discov."},{"key":"6715_CR44","doi-asserted-by":"publisher","unstructured":"Vareslija, D. et al. Transcriptome characterization of matched primary breast and brain metastatic tumors to detect novel actionable targets. J. Natl Cancer Inst. djy110, https:\/\/doi.org\/10.1093\/jnci\/djy110 (2018).","DOI":"10.1093\/jnci\/djy110"},{"key":"6715_CR45","doi-asserted-by":"publisher","first-page":"180024","DOI":"10.1038\/sdata.2018.24","volume":"5","author":"Antonio Garc\u00eda-Alix","year":"2018","unstructured":"Salomon, M. P. et al. Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical features. Sci. Data\u00a0doi: 10.1038\/sdata.2018.245 (2018).","journal-title":"Scientific Data"},{"key":"6715_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-1-59745-522-0_23","volume":"507","author":"M Campan","year":"2009","unstructured":"Campan, M., Weisenberger, D. J., Trinh, B. & Laird, P. W. MethyLight. Methods Mol. Biol. 507, 325\u2013337 (2009).","journal-title":"Methods Mol. Biol."},{"key":"6715_CR47","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond, M. E. et al. American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Clin. Oncol. 28, 2784\u20132795 (2010).","journal-title":"J. Clin. Oncol."},{"key":"6715_CR48","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff, A. C. et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J. Clin. Oncol. 31, 3997\u20134013 (2013).","journal-title":"J. Clin. Oncol."},{"key":"6715_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-6-r44","volume":"13","author":"J Maksimovic","year":"2012","unstructured":"Maksimovic, J., Gordon, L. & Oshlack, A. SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips. Genome Biol. 13, R44 (2012).","journal-title":"Genome Biol."},{"key":"6715_CR50","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71 (2016).","journal-title":"Nucleic Acids Res."},{"key":"6715_CR51","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0076-6879(06)11009-5","volume":"411","author":"AI Saeed","year":"2006","unstructured":"Saeed, A. I. et al. TM4 microarray software suite. Methods Enzymol. 411, 134\u2013193 (2006).","journal-title":"Methods Enzymol."},{"key":"6715_CR52","first-page":"2579","volume":"9","author":"LJP van der Maaten","year":"2008","unstructured":"van der Maaten, L. J. P. & Hinton, G. Visualizing Data using t-SNE. J. Mach. Learn. Res. 9, 2579\u20132605 (2008).","journal-title":"J. Mach. Learn. Res."},{"key":"6715_CR53","first-page":"3221","volume":"15","author":"L van der Maaten","year":"2014","unstructured":"van der Maaten, L. Accelerating t-SNE using Tree-Based Algorithms. J. Mach. Learn. Res. 15, 3221\u20133245 (2014).","journal-title":"J. Mach. Learn. Res."},{"key":"6715_CR54","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1158\/0008-5472.CAN-17-0580","volume":"77","author":"Y Newton","year":"2017","unstructured":"Newton, Y. et al. TumorMap: exploring the molecular similarities of cancer samples in an interactive portal. Cancer Res. 77, e111\u2013e114 (2017).","journal-title":"Cancer Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06715-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06715-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06715-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T15:02:13Z","timestamp":1671548533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06715-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,6]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["6715"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-06715-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/268193","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,6]]},"assertion":[{"value":"5 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4627"}}